Laura Shawver, Silverback
Silverback files to go public, potentially adding to this year's record-high biotech IPO raise
The signs were there: A couple of months ago, Silverback Therapeutics quickly pulled in $163 million in two back-to-back rounds for what CEO Laura …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
